A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

Cancer
Skin Cancer
Melanoma
Mucosal Melanoma
Cutaneous Melanoma

Results
Download
Print

Study results

LPS BP42169 Final Results April 2023 English (PDF, 1.6 MB)

LPS BP42169 Final Results April 2023 Spain Spanish (PDF, 0.8 MB)

LPS BP42169 Final Results May 2023 France French (PDF, 0.1 MB)

LPS BP42169 Final Results May 2023 Netherlands Dutch (PDF, 0.2 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

Study results

LPS BP42169 Final Results April 2023 English (PDF, 1.6 MB)

LPS BP42169 Final Results April 2023 Spain Spanish (PDF, 0.8 MB)

LPS BP42169 Final Results May 2023 France French (PDF, 0.1 MB)

LPS BP42169 Final Results May 2023 Netherlands Dutch (PDF, 0.2 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

For the latest version of this information please go to www.forpatients.roche.com